Indberetningsfrekvensen for bekræftede tilfælde af rabdomyolyse ved monoterapi med 0, 2- 0, 8 mg cerivastatin er højere end for de øvrige statiner.
The reporting rates of confirmed cases of rhabdomyolysis in association with 0.2mg to 0.8mg cerivastatin monotherapy are greater than those with any of the other statins.